Search details
1.
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women.
N Engl J Med
; 385(7): 595-608, 2021 08 12.
Article
in English
| MEDLINE | ID: mdl-34379922
2.
Sexual behavior and medication adherence in men who have sex with men participating in a pre-exposure prophylaxis study of combinations of Maraviroc, Tenofovir Disoproxil Fumarate and/or Emtricitabine (HPTN 069/ACTG 5305).
AIDS Behav
; 26(12): 4107-4114, 2022 Dec.
Article
in English
| MEDLINE | ID: mdl-35687192
3.
Acceptability of Long-Acting Injectable Cabotegravir (CAB LA) in HIV-Uninfected Individuals: HPTN 077.
AIDS Behav
; 24(9): 2520-2531, 2020 Sep.
Article
in English
| MEDLINE | ID: mdl-32052214
4.
Antiretroviral Therapy for the Prevention of HIV-1 Transmission.
N Engl J Med
; 375(9): 830-9, 2016 09 01.
Article
in English
| MEDLINE | ID: mdl-27424812
5.
Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial.
PLoS Med
; 15(11): e1002690, 2018 11.
Article
in English
| MEDLINE | ID: mdl-30408115
6.
Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Women: A Phase 2 Randomized Trial.
Ann Intern Med
; 167(6): 384-393, 2017 Sep 19.
Article
in English
| MEDLINE | ID: mdl-28828489
7.
Phase 2 Study of the Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Men Who Have Sex With Men (HPTN 069/ACTG A5305).
J Infect Dis
; 215(2): 238-246, 2017 Jan 15.
Article
in English
| MEDLINE | ID: mdl-27811319
8.
Correction to "Identification of Novel UGT1A1 Variants Including UGT1A1 454C>A through the Genotyping of Healthy Participants of the HPTN 077 Study".
ACS Pharmacol Transl Sci
; 4(4): 1462, 2021 Aug 13.
Article
in English
| MEDLINE | ID: mdl-35783008
9.
Identification of Novel UGT1A1 Variants Including UGT1A1 454C>A through the Genotyping of Healthy Participants of the HPTN 077 Study.
ACS Pharmacol Transl Sci
; 4(1): 226-239, 2021 Feb 12.
Article
in English
| MEDLINE | ID: mdl-33615175
10.
Brief Report: Hormonal Contraception Use and Cabotegravir Pharmacokinetics in HIV-Uninfected Women Enrolled in HPTN 077.
J Acquir Immune Defic Syndr
; 85(1): 93-97, 2020 09 01.
Article
in English
| MEDLINE | ID: mdl-32452972
11.
Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trial.
Lancet HIV
; 7(7): e472-e481, 2020 07.
Article
in English
| MEDLINE | ID: mdl-32497491
12.
Genetic Variation of the Kinases That Phosphorylate Tenofovir and Emtricitabine in Peripheral Blood Mononuclear Cells.
AIDS Res Hum Retroviruses
; 34(5): 421-429, 2018 05.
Article
in English
| MEDLINE | ID: mdl-29455571
Results
1 -
12
de 12
1
Next >
>>